Study in Primary Care Evaluating Inclisiran Delivery Implementation + Enhanced Support

Clinical trial NCT04807400 · COMPLETED

Trial details

NCT number: NCT04807400
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Atherosclerotic Cardiovascular Disease Atherosclerotic Cardiovascular Disease Risk Equivelents Elevated Low Density Lipoprotein Cholesterol

Start date: 2021-07-07
Primary completion: 2023-01-13
Enrollment: 892

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.